BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31956010)

  • 1. Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
    Schulz GB; Grimm T; Buchner A; Jokisch F; Kretschmer A; Stief CG; Knüchel R; Kraywinkel K; Karl A
    Clin Genitourin Cancer; 2020 Jun; 18(3):162-170.e4. PubMed ID: 31956010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
    Scosyrev E; Wu G; Golijanin D; Messing E
    Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer incidence rates and trends in young adults aged 20-39 years.
    Palumbo C; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI
    Urol Oncol; 2020 Dec; 38(12):934.e11-934.e19. PubMed ID: 32653412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.
    Nielsen ME; Smith AB; Meyer AM; Kuo TM; Tyree S; Kim WY; Milowsky MI; Pruthi RS; Millikan RC
    Cancer; 2014 Jan; 120(1):86-95. PubMed ID: 24122346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of population-based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences.
    Caballero JM; Gili JM; Pereira JC; Gomáriz A; Castillo C; Martín-Baranera M
    Cancer Med; 2023 Mar; 12(6):7540-7551. PubMed ID: 36530046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Ray-Zack MD; Hudgins HK; Jazzar U; Tyler DS; Freedland SJ; Swanson TA; Baillargeon JG; Hu JC; Kaul S; Kamat AM; Gore JL; Mehta HB
    JAMA Surg; 2019 Aug; 154(8):e191629. PubMed ID: 31166593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals.
    Fakhry C; Krapcho M; Eisele DW; D'Souza G
    Cancer; 2018 May; 124(10):2125-2133. PubMed ID: 29533459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
    Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
    Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends.
    Huang J; Ngai CH; Deng Y; Pun CN; Lok V; Zhang L; Xu Q; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
    Endocrine; 2023 May; 80(2):355-365. PubMed ID: 36607509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location.
    Wong MCS; Huang J; Lok V; Wang J; Fung F; Ding H; Zheng ZJ
    Clin Gastroenterol Hepatol; 2021 May; 19(5):955-966.e61. PubMed ID: 32088300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which data are available in central registries on bladder cancer patients in the five Nordic countries.
    Körner SK; Dreyer T; Haug ES; Jerlström T; Boström PJ; Gudjonsson S; Jensen JB
    Scand J Urol; 2021 Apr; 55(2):135-141. PubMed ID: 33504267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
    Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL
    Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania.
    Bann DV; Goyal N; Camacho F; Goldenberg D
    JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1149-56. PubMed ID: 25170647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
    Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
    Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
    Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
    Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
    Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.
    Maruf M; Sidana A; Purnell S; Jain AL; Brancato SJ; Agarwal PK
    Int Urol Nephrol; 2018 Feb; 50(2):257-262. PubMed ID: 29275528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.